How should I manage a 40-year-old male with persistent ear fullness and reduced hearing after a recent otitis media, intermittent phantom TV-like noise, anxiety and depression not controlled on venlafaxine 75 mg, daily alprazolam use, and hypertension with elevated home blood pressures?

Management Approach

This patient requires ENT referral for likely otitis media with effusion (OME), optimization of his venlafaxine dose to 150-225 mg/day for inadequate anxiety/depression control, and intensification of his hypertension management given elevated home blood pressures.

Ear Management: Persistent Middle Ear Effusion

The clinical presentation—persistent ear fullness, reduced hearing, "bubble-like appearance" behind the tympanic membrane following recent otitis media, and phantom auditory sensations—strongly suggests otitis media with effusion (OME). The bubble-like appearance is characteristic of middle ear fluid.

Immediate Actions:

• Refer to ENT for evaluation and possible tympanometry/audiometry 1
• While OME guidelines focus on pediatric populations, the principles apply: most OME resolves spontaneously within 3 months, but 25% persist beyond 3 months and can cause hearing loss and quality of life impairment 1
• Given his history of prolonged ear infection requiring ENT evaluation with residual hearing loss, and current symptoms worse than baseline, specialist evaluation is warranted to assess for:
  • Persistent effusion requiring intervention
  • Eustachian tube dysfunction
  • Structural damage to tympanic membrane
  • Baseline hearing assessment

Tinnitus Component:

The "phantom TV noise" represents tinnitus, likely secondary to conductive hearing loss from the middle ear effusion. Do not prescribe medications specifically for tinnitus 2. The tinnitus guideline explicitly recommends against routine use of antidepressants, anticonvulsants, or anxiolytics for primary tinnitus treatment 2. Once hearing is addressed through OME management, tinnitus may improve. If it persists after ear treatment, consider hearing aid evaluation if hearing loss remains 2.

---

Psychiatric Management: Inadequate Anxiety/Depression Control

Venlafaxine Optimization:

The patient reports venlafaxine 75 mg is "no longer working as well" with GAD-7 score of 16 (moderate-severe anxiety), chest pressure, palpitations, and increased alprazolam use (now daily).

Increase venlafaxine to 150 mg/day immediately 3. The FDA label states:

• Starting dose: 75 mg/day
• May increase to 150 mg/day based on tolerability and clinical need
• Can further increase up to 225 mg/day
• Dose increases of up to 75 mg/day should occur at intervals of no less than 4 days 3

Rationale:

• Current dose (75 mg) is the minimum starting dose
• Therapeutic range for depression/anxiety is typically 150-225 mg/day 3
• His symptoms indicate inadequate response requiring dose escalation
• Venlafaxine is first-line for generalized anxiety disorder 4

Alprazolam Management:

• Do not increase alprazolam—daily benzodiazepine use indicates tolerance/dependence risk
• As venlafaxine is optimized, work toward reducing alprazolam to PRN use only
• Counsel on risks of daily benzodiazepine use

Follow-up Plan:

• Reassess in 2-3 weeks after dose increase
• If inadequate response at 150 mg after 4+ weeks, increase to 225 mg/day
• Consider psychiatry referral if symptoms persist despite optimization to 225 mg/day
• Revisit therapy options with focus on finding better therapeutic fit or addressing insurance barriers

---

Hypertension Management: Inadequate Control

Critical Issue:

Patient reports home blood pressures "usually higher" than today's office reading, despite being on losartan 100 mg + metoprolol succinate 25 mg. This indicates inadequate control.

Venlafaxine and Blood Pressure:

Important caveat: Venlafaxine causes dose-dependent blood pressure elevation 3, 5:

• At doses <100 mg/day: 3% incidence of sustained hypertension
• At 101-200 mg/day: 5% incidence
• At 201-300 mg/day: 7% incidence
• At >300 mg/day: 13% incidence 3

The FDA label explicitly states: "Pre-existing hypertension should be controlled before treatment with venlafaxine" and recommends "regular monitoring of blood pressure" 3.

Management Strategy:

1. Before increasing venlafaxine, optimize blood pressure control:

   • Increase metoprolol succinate to 50-100 mg daily, OR
   • Add amlodipine 5-10 mg daily (preferred given already on beta-blocker + ARB)

2. Obtain home blood pressure log over 1-2 weeks to assess true control

3. Monitor blood pressure closely after each venlafaxine dose increase

4. If blood pressure becomes uncontrolled after venlafaxine escalation, either:

   • Further intensify antihypertensive therapy, OR
   • Consider alternative antidepressant (though venlafaxine is optimal for his anxiety)

---

Other Medications

• Continue rosuvastatin 5 mg for hyperlipidemia
• Continue monitoring for hereditary hemochromatosis per established protocol
• Document Repatha discontinuation due to cost

---

Key Monitoring Parameters

• Week 2-3: Blood pressure check, anxiety/depression symptom assessment after venlafaxine increase
• Week 4-6: ENT follow-up for ear evaluation; consider further venlafaxine titration if needed
• Ongoing: Home blood pressure monitoring, GAD-7/PHQ-9 scores at visits

---

Critical Pitfalls to Avoid

1. Do not treat tinnitus with medications—it's likely secondary to OME and will improve with ear treatment 2
2. Do not ignore elevated home blood pressures—office readings may not reflect true control; venlafaxine will worsen this 3, 5
3. Do not continue subtherapeutic venlafaxine dosing—75 mg is inadequate for most patients with anxiety/depression 3
4. Do not delay ENT referral—history of prolonged infection with residual hearing loss + current worsening warrants specialist evaluation 1
5. Be aware venlafaxine can cause tinnitus—recent pharmacovigilance data shows association between venlafaxine and inner ear symptoms including tinnitus 6, though in this case the temporal relationship suggests OME as primary cause